how do genetics play a role in the treatment of cf

Genetics play a role in cystic fibrosis, as everyone carries the CFTR gene, but only a few people have a mutation. If both parents have the mutation passed on, the offspring can then get cystic fibrosis.

Full Answer

Does Genetics still play a role in cystic fibrosis research?

Carrier (or genetic) testing not only plays a key role in the diagnosis of cystic fibrosis, but testing also allows parents to find out what their chances are of having a child with CF to help inform important family planning decisions.

What is the role of CFTR in the pathophysiology of cystic fibrosis?

THE ROLE OF GENETICS. Cystic fibrosis (CF) is a genetic disease caused by specific changes (mutations) in our genetic material. Our genetic material – DNA – is a combination of genes inherited from our parents. The information is stored in DNA as a code made up of different “letters”. Any change in the “letters” could cause defects in the final gene product – the protein.

What drives variation in cystic fibrosis (CF) traits?

Abstract. Genetics is the branch of biology concerned with study of individual genes and how they work whereas genomics is involved with the analysis of all genes and their interactions. Both of these approaches have been applied extensively to CF. Identification of the CFTR gene initiated the dissection of CF genetics at the molecular level.

Can I Pass on my CF gene to my child?

Cystic fibrosis is caused by mutations in the gene that produces the cystic fibrosis transmembrane conductance regulator (CFTR) protein. In people with CF, mutations in the CFTR gene can disrupt the normal production or functioning of the CFTR protein found in the cells of the lungs and other parts of the body.

What role does genetics play in cystic fibrosis?

How is CF cystic fibrosis a genetic advantage?

What are the implications of using gene therapy to cure CF?

Is gene therapy being used to treat cystic fibrosis?

How does genetic therapy work?

What treatments are available for cystic fibrosis?

How is gene therapy used to treat SCID?

How does CF affect biological maturation?

What are researchers doing to the mutated gene when they use gene therapy?

What is the role of genetics in CF?

THE ROLE OF GENETICS. Cystic fibrosis (CF) is a genetic disease caused by specific changes (mutations) in our genetic material. Our genetic material – DNA – is a combination of genes inherited from our parents. The information is stored in DNA as a code made up of different “letters”. Any change in the “letters” could cause defects in ...

What is CF caused by?

CF is caused by mutations in the CFTR gene 1,2. The CFTR gene codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Each person has two copies of the gene, one inherited from each parent. CF is a recessive disease, meaning that it manifests only if a person has two copies that contain mutations (i.e., are defective).

What is class VI mutation?

Class VI: These mutations result in a reduction of protein stability, where the protein is degraded rapidly. Examples include c.120del23 or rF508del (r = rescued). When you have CF, it is important to know what defects your genetic mutations cause, because they require different therapeutic approaches.

What is the chance of a child having CF?

25 % that the child will not be a carrier or have CF. If one of the parents has CF, the child will have CF with a 50 % chance if the other parent is a carrier. If both parents have CF, all their children will inherit CF.

How many variants of CFTR are there?

So far, there have been more than 2000 described variants of the CFTR gene, but not all of them cause CF 5. Only a much smaller number of mutations is commonly present in people with CF. Each person with CF has two mutations – these can be the same or different.

What is the chance of having CF in two parents?

If two carriers have a child, the chances are: If one of the parents has CF, the child will have CF with a 50 % chance if the other parent is a carrier.

Why does a protein need to fold?

The synthesized protein needs to fold correctly because its spatial structure is important for proper function. Then the mature protein moves through the cell to get to the cell surface, where it serves in the membrane as a channel to transport ions from the inside of the cell to the outside.

What is the function of CFTR?

The CFTR gene is a protein that functions as a chloride channel. A chloride channel helps maintain the proper balance of salt and water within a cell. A mutation in CFTR causes a dysfunction of the salt and water balance. This causes dehydration of the secretions (thick mucous) and excessive loss of salt in sweat.

How does cystic fibrosis occur?

Cystic fibrosis occurs when both genes in the pair have a mutation. A person with cystic fibrosis inherits one CF gene from each parent. Cystic fibrosis is a genetic disorder caused by inheriting a pair of genes that are mutated or not working properly.

How many copies of the CFTR gene are there?

The Cystic Fibrosis Gene. Everyone inherits two copies of the CFTR (cystic fibrosis transmembrane conductance regulator) gene. However, some of the inherited copies are mutations. To date, over 700 mutations of the CFTR gene have been identified.

What is the unit of heredity?

A gene is the basic unit of heredity. Genes are responsible for the physical characteristics that each person has (like eye color, facial features, and many health conditions). Each gene occupies a certain location on a chromosome (a thread-like material that is located in the nucleus of every single cell in the body).

What is a carrier gene?

A carrier is a person who only has one copy of the mutated gene. The parents of a child with CF each carry one CF gene and one normal gene. They have no symptoms and no disease.

How do genes work?

Each gene has a specific role in determining how a person's body is put together and how it functions. The role of a gene is determined by its individual DNA code (deoxyribonucleic acid, the chemical coding for a gene). DNA is made up of four building blocks called bases. These bases are joined in a specific order for each gene.

What are the building blocks of DNA?

DNA is made up of four building blocks called bases . These bases are joined in a specific order for each gene. When a change occurs in the arrangement of the bases, it can cause the gene not to work properly.

What is the most common disease causing variant with a frequency of about 70% in CF population?

Among these is F508del, a three nucleotide deletion that leads to the omission of a phenylalanine residue at codon 508. The F508del is the most common disease causing variant with a frequency of about 70% in CF population.

What organ systems are affected by CFTR?

In general, variants that cause complete or near complete loss of CFTR function results in severe features in the organ systems primarily affected in CF (i.e., lungs, pancreas, intestine and sweat gland). However, there can be considerable intra- and inter- individual differences in the degree of organ dysfunction.

How many variants are there in CFTR2?

As of 2019, nearly 90,000 individuals recruited by the CFTR2 project world-wide carry 1640 different CFTRvariants. The goal of the project is to assess the disease-liability of all CFTRvariants and, as of late 2019, this has been completed for 412 of the most common variants (https://cftr2.org/).Thenon-linearrelationshipbe-tween increases of CFTR function and a response in the phenotype indicates that even minor improvements in function for individuals with severe disease could produce a clinically relevant change in outcome. The triple combination modulator therapy is expected to be clinically efficacious for ~ 93% of individuals with CF worldwide. Individuals who carry non-responsive variants in each CFTRgene will require alternative therapies. Gene modifier studies have estimated the effect of genetic and non-genetic factor st opheno-ty pevariabilit y.Modifie rs oflung functio n,meconi umile ussuscep-tibili tygene s,and modifiers of CFrelat eddiabet esha vebe eneluci-dat edusi nggeno mewi deapproache s.Targeti ng ofmodifie rscould augme ntmodulat ortherapy a ndprovi detreatme ntf orindividuals w hocar ryvarian tsthat a reunresponsi ve toCF TRmodulators.

Where are CFTR variants tested?

CF Foundation has sponsored a highthroughput approach to functional and modulator testing using the combined efforts of laboratories at UT Southwestern, Rosalind Franklin (Chicago) and the CF Therapeutics Lab in Boston. It should be noted that quite a few of the variants cause minimum to no effect on CFTR function, indicating that they are likely benign variants. There are also situations where CFTR variants alter other functions of CFTR like bicarbonate transport that are not routinely assayed [24]. Furthermore, the combination of two or more variants in the same CFTRgene (a.k.a. complex alleles) present a particular challenge [25–28]. There are over 120 complex alleles already recorded in CFTRand more are likely tobe discovered as sequencing of the entire CFTRgene becomes routine. Although these variants of ‘variable clinical consequence’ represent only 5% of all CFTRvariants interpreted thus far, they can create substantial challenges when trying to establish a diagnosis of CF.

What is the difference between genetics and genomics?

Genetics is the branch of biology concerned with study of individual genes and how they work whereas genomics is involved with the analysis of all genes and their interactions. Both of these approaches have been applied extensively to CF. Identification of the CFTRgene initiated the dissection of CF genetics at the molecular level.

Does lung function vary over decades?

In contrast, variation in lung function manifests over decades. These observations indicated that the nature of the defect in the CFTRgene contributed to variation in severity, but other factors, notably genetic and environmental modifiers are important determinants of phenotype variability.

Does CFMD cause CF?

Thus, only a fraction of the CFMD variants cause CF and the status of many other variants is unclear.

What is the cause of cystic fibrosis?

Cystic fibrosis is caused by mutations in the gene that produces the cystic fibrosis transmembrane conductance regulator (CFTR) protein.

How many copies of the CFTR gene are there?

Every person has two copies of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. A person must inherit two copies of the CFTR gene that contain mutations -- one copy from each parent -- to have cystic fibrosis.

What causes CFTR to not work?

At other times, the change in a gene may cause the protein to not work or not be made at all. Cystic fibrosis is caused by mutations in the gene that produces the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This protein is responsible for regulating the flow of salt and fluids in and out of the cells in different parts of the body.

What is the function of genes in a chromosome?

Each chromosome is made up of many genes, which are the entries, or topics, in the encyclopedia. The genes supply the body with instructions for making proteins.

What would happen if we all shared 100 percent of our genetic material?

If we all shared 100 percent of our genetic material then we would all be as alike as identical twins are. But not every single letter in the genetic encyclopedia is the same in all of us, which helps to explain why we are not all exactly alike.

Can CF carriers pass CFTR mutations to their children?

CF carriers can pass their copy of the CFTR gene mutation to their children. Each time two CF carriers have a child together, the chances are:

What is the purpose of each cell in the human body?

Each of our cells contains genetic information that provides the body with coded instructions to make proteins, which determine how the body looks, develops, and works.

What is the role of growth factor beta 1 in cystic fibrosis?

Transforming growth factor beta 1 (TGFBl)was an intriguing candidate for a modifier of cystic fibrosis lung disease, as it is involved in tissue repair and extracellular matrix production. Furthermore, variants in TGFBlhave been associated with risk of asthma and chronic obstructive pulmonary disease (COPD) -two conditions that have features in common with cystic fibrosis lung disease. Two variants that increase levels ofTGFBl were correlated with severe lung disease as determined by airway flow measurements81. However, the direction of effect differs between cystic fibrosis and COPD; the same alleles show a deleterious consequence in one disorder but a protective effect in the other. It has been speculated that the presence of functional CFTR may invert the clinical consequences of increased TGFBlexpression in individuals with COPD81Gene-gene and gene-environment studies using TGFBlvariants have begun to address the issue of context. An obvious first place to look for gene-gene interaction is between TGFBlmodifier variants and CFTRdisease-causing variants. Drumm, Knowles and colleagues established TGFBlas a modifier primarily in individuals who are homozygous for the common cystic fibrosis-causing variant F508del81. A subsequent study demonstrated that the alternative alleles of the same TGFBlvariants were associated with less severe lung disease, but the effect was limited to individuals with CFTRgenotypes other than F508del homozygosity82. Interaction has been reported between TGFBland mannose-binding lectin 2 (MBL2),which is another genetic modifier of cystic fibrosis . Variants associated with increased TGFBlexpression amplify the deleterious effects of MEL deficiency upon lung infection and airway deterioration84. Environmental context is also important, as variants in TGFBlexacerbate the pernicious effects of exposure to second-hand smoke in patients with cystic fibrosis85. These observations indicate that deducing the clinical effect of a modifier variant greatly depends on the context in which it occurs.

What is the most common cause of cystic fibrosis?

Twenty-five years ago, a variant (p.Phe508del; also known as F508del in legacy nomenclature) in the cystic fibrosis transmembrane conductance regulator (CFTR)gene was found to be the most common cause of cystic fibrosis3-5. Demonstration that CFTR functions as a chloride channel regulated by cyclic AMP (cAMP)-dependent phosphorylation 6was consistent with the ion transport disturbances documented in cystic fibrosis tissuesM Key insights into cystic fibrosis pathophysiology were derived from the study of CFTR mutants9, correlation ofCFTR dysfunction with the cellular manifestations of cystic fibrosis10and elucidation of protein partners involved in biogenesis and membrane functionu Identification of disease-causing variants in CFTRcontributed a tool for both the diagnosis of cystic fibrosis and the identification of cystic fibrosis carriers12, demonstrated the degree to which CFTR dysfunction correlates with clinical features1and revealed that CFTR dysfunction can create phenotypes other than cystic fibrosis14Over the past 5 years, there has been remarkable progress in the development of small-molecule therapy targeting CFTR bearing select disease-causing variants15,16

What are the best animal models for cystic fibrosis?

Cystic fibrosis is unique among human genetic disorders in that five animal models (mouse38, rat39, ferret40, pig41and zebrafish42) have been created. Although these animal models have not replicated human cystic fibrosis precisely, their differences have proved to be highly instructive for understanding disease mechanisms at the organ-system level (TABLE 1). The Cftrgene in mice has been extensively manipulated to derive lines that do not express CFTR and lines that express CFTR bearing variants equivalent to those observed in humans (for example, F508del and p.Gly551Asp (legacy G551D)) 4. Even though airway epithelial cells display ion transport abnormalities that are consistent with loss of CFTR function, overt lung disease is not evident in newborn or young mice with cystic fibrosis44. The absence of lung disease similar to that seen in humans with cystic fibrosis has been ascribed to the presence of alternative pathways for chloride transport in mouse epithelial cells45. This observation suggests that ion channels other than CFTR might be exploited to recover chloride transport in cystic fibrosis cells. Indeed, a suitable candidate may have already been identified in TMEM16A(also known as ANOl),which encodes a calcium-activated chloride channel first identified in mouse airways46. Despite the phenotypic differences between mice and humans, the study of cystic fibrosis mouse models has provided invaluable insights into the role of other ion channels in the development of lung disease, the biology ofintestinal obstruction and the evaluation of candidate modifiers47, and such models also provide an in vivoplatform for testing therapeutics43.

What are the most relevant systems for CFTR?

Tissue culture. Assessment of the functional consequence of variants requires the appropriate cellular context. For CFTR, primary epithelial cells are the most relevant system; however, these cells are short-lived and require accessioning from internal organs such as the lung . Furthermore, availability and compliance substantially limit acquisition of primary cells from individuals with rare CFTRgenotypes. Recent advances in stem cell biology have provided new methods for generating well-differentiated cell lines from individuals with cystic fibrosis. Human embryonic stem cells and intestinal stem cells from individuals with cystic fibrosis have been coaxed into differentiating into secretory epithelial cells that manifest defects in CFTR-mediated chloride transport34,35. Small-molecule correctors for the F508del variant were efficacious in restoring CFTR function in both cell types, which showed the utility of these systems for evaluating therapeutics32,34. Genetic reversion of the F508del variants to wild type using CRISPR-Cas9 editing has been achieved in intestinal organoids36. Conversion of well-differentiated epithelial cells from human ectocervix and trachea into 'conditionally reprogrammed' cells using Rho kinase inhibitor offers an alternative approach to derive individual-specific cell types37.These methods provide new tissue models for examining function and dysfunction of CFTR from individuals with specific CFTRgenotypes.

How many variants are there in CFI?

Molecular basis of CFI'R dysfunction. Almost 2,000 variants have been reported to the Cystic FibrosisMutation Database, one of the first and most successful locus-specific databases. Among these variants, 40% are predicted to cause substitution of a single amino acid, 36% are expected to alter RNA processing (including nonsense, frameshift and mis-splicing variants), 3% involve large rearra ngem ents of CFTR,and 1% affects promoter regions; 14% seem to be neutral variants, and the effect of the remaining 6% is unclear. Diseasecausing variants can affect the quantity and/or function of CFTR at the cell membrane (FIG 2). Historically, CFTRvariants have been grouped into five (and sometimes six) functional classes9The class system provides a useful framework for understanding the primary defect at the cellular level. However, binning of variants into one class is problematic, as multiple processes can be affected by a single variant. For example, F508del causes aberrant folding ofCFTR and subsequent degradation of the majority of the synthesized protein 17The minor fraction of F508del-CFTR that is trafficked to the cell membrane has severely reduced membrane residency and aberrant chloride channel function18. Furthermore, the three-nucleotide deletion responsible for the F508del variant also causes a synonymous change in the triplet that encodes isoleucine at codon 507 (ATC-7ATT). The change alters the structure of the F508del-CFTR mRNA, which leads to a reduction in translation efficiency19. Thus, F508del could be assigned to at least three classes. Various missense variants also cause defective processing and alter chloride channel function of CFTR20,21. Appreciating the diversity of effects caused by a CFTRvariant is important in the design of molecular treatments for cystic fibrosis (see below).

What are disease-causing variants?

Disease-causing variants provide a reservoir of naturally occurring deleterious amino acid deletions and substitutions that have proved to be informative for dissecting the tertiary structure of CFTR. CFTR is composed of three major motifs: domains that interact with ATP, termed nucleotide-binding domain 1 (NBDl) and NBD2; regions that anchor the protein in the membrane known as membrane-spanning domain 1 (MSD 1) and MSD2; and an area containing numerous sites for phosphorylation called the regulatory domain (also known as the R domain) (FIG 2). It had been recognized for some time that deletion of phenylalanine at codon 508 (F508) causes instability of NBD 1, but how this localized structural defect causes m isfolding of the entire protein was poorly understood22. Furthermore, it was known that disease-causing missense variants outside the NBD 1 domain - notably, a cluster in the fourth cytosolic loop (CL4) within MSD2 -also cause misfolding of the protein2,24. Modelling based on the atomic structure of related proteins25,26and cysteinecrosslinking experiments27revealed an interaction between the NBDs and MSDs of CFTR. Notably, F508 occurs at an interface between NBDl and CL4, and seems to be capable of forming hydrogen bonds with arginine at codon 1070 (R1070)26. Restoration of NBD 1 assembly using suppressor mutations produces only partial recovery of CFTR processing, which indicates that the F508del variant also affects interactions elsewhere in the full-length protein 28. Intriguingly, introduction of the disease-associated p.Arg1070Trp (legacy R1070W)29variant in CL4 and correction of NBD 1 misfolding using synthetic suppressor mutations could restore processing to F508del-CFTR 28,30,31. These findings lay the groundwork for structure-based selection of molecules that correct the processing defects in CFTR caused by disease-causing variants32.

Is cystic fibrosis a mammalian disease?

Mammalian models of cystic fibrosis have also provided insights into disease processes in other affected organ systems. Pancreatic exocrine dysfunction is closely correlated with the development of neonatal intestinal obstruction in humans with cystic fibrosis. However, animal models exhibit minimal (mouse) to severe (pig) pancreatic exocrine disease com pared with humans, yet the incidence of intestinal obstruction is higher in all mammalian models than in humans (TABLE 1). Recovery of intestinal expression of CFTR prevents obstruction in cystic fibrosis mice, pigs and ferrets40,55,56.These two observations suggest that loss of CFTR function in the intestine rather than pancreatic exocrine dysfunction is the primary cause of intestinal obstruction in cystic fibrosis. Diabetes mellitus is an age-dependent complication that affects 40% of individuals with cystic fibrosis by 35 years of age2this disorder is also closely correlated with pancreatic exocrine dysfunction. Destruction of the exocrine pancreas has been proposed to stress the endocrine pancreas, which leads to loss of insulin-secreting cells57. However, features of diabetes occur before the development of severe pancreatic exocrine disease in ferrets58and in the absence of substantial loss of insulin-producing cells in cystic fibrosis pigs59. Both observations suggest that cystic fibrosisrelated diabetes is the result of an intrinsic defect in the endocrine pancreas caused by loss of CFTR function.

Why is it important to understand the role of genes in CF?

The specific genes that cause their CF will also affect the types of medication that may work for them. That’s why it’s so important to understand the part genes play in CF when making decisions about your child’s healthcare.

How many mutations are there in CF?

According to the Cystic Fibrosis Foundation (CFF), scientists have identified more than 1,700 different types of mutations in the gene that can cause CF. To develop CF, your child must inherit two mutated copies ...

Why are CFTR proteins not produced?

Depending on the specific type of genetic mutations that your child has, they might be unable to produce CFTR proteins. In other cases, they might produce CFTR proteins that don’t work properly. These defects cause mucus to build up in their lungs and puts them at risk of complications.

What is the process of matching medications to different mutations in the CFTR gene?

This process is known as theratyping. It can potentially help your child’s doctor determine which treatment plan is best for them.

How many CFTR modulators have been approved?

So far, the U.S. Food and Drug Administration (FDA) has approved three CFTR modulator therapies: About 60 percent of people with CF could benefit from one of these drugs, reports the CFF. In the future, scientists hope to develop other CFTR modulator therapies that could benefit more people.

How many groups are there in the CFTR gene?

Scientists have developed different ways to classify mutations in the CFTR gene. They currently sort CFTR gene mutations into five groups, based on the problems they can cause:

What happens if your child has cystic fibrosis?

Share on Pinterest. If your child has cystic fibrosis (CF), then their genes play a role in their condition. The specific genes that cause their CF will also affect the types of medication that may work for them.

Genetic Mutations and Cystic Fibrosis (CF)

Cystic Fibrosis is primarily caused by genetic mutations that take place in the cystic fibrosis transmembrane conductance regulator, commonly referred to as the CFTR gene. The CFTR gene has a role to play in the production of CFTR proteins.

How Does Genetic Mutation Impact Cystic Fibrosis Treatment?

Over the last couple of years, researchers have started matching the different types of medications for cystic fibrosis to the different types of genetic mutations present in the CFTR gene. This process is called theratyping and can potentially help doctors determine the best treatment plan for a child suffering from cystic fibrosis.

How to Know If the Treatment for Cystic Fibrosis is Right?

If you want to know whether your child can benefit from using a CFTR modulator or any other treatment of cystic fibrosis, then you will have to consult their doctor. In certain cases, the doctor will prescribe tests that will help them learn more about the child’s condition and the gene mutation.

Conclusion

Different types of genetic mutations are responsible for causing cystic fibrosis (CF). The same specific types of mutations can now also have an influence on the child’s symptoms, as well as their treatment plan for cystic fibrosis.

How to test for CF mutation?

Testing for the CF gene can be done from a small blood sample or from a "cheek swab," which is a brush rubbed against the inside of your cheek to obtain cells for testing. Laboratories generally test for the most common mutations, and most labs test for anywhere from 30 to 100 total mutations.

Who should test for CF?

Testing for the CF gene is recommended for anyone who has a family member with the disease, or whose partner is a known carrier of CF or affected with CF.

What is the 7th chromosome?

The seventh pair of chromosomes contains a gene called the CFTR (cystic fibrosis transmembrane regulator) gene . Mutations or errors in this gene are what cause CF. This gene is quite large and complex. Over 1,000 different mutations in this gene have been found which cause CF.

What is autosomal recessive?

"Recessive" means that two copies of the gene, one inherited from each parent, are necessary to have the condition.

How many chances are there for another child to have CF?

This means that there is a three out of four, or 75 percent chance, for another child to not have CF.

Is CF inherited?

Directions. Contact Us. The Genetics of Cystic Fibrosis. Cystic fibrosis (CF) is a genetic disease. This means that CF is inherited. A child will be born with CF only if two CF genes are inherited - one from the mother and one from the father. A person who has only one CF gene is healthy and said to be a "carrier" of the disease.

Is CF a family history?

The birth of a child with CF is often a total surprise to a family, since most of the time there is no previous family history of CF. Many autosomal recessive conditions occur this way.

What Is A Gene?

What happens?

What Are Genetic Disorders?

The Cystic Fibrosis Gene

What Does The Mutation do?

• The CFTR gene is a protein that functions as a chloride channel. A chloride channel helps maintain the proper balance of salt and water within a cell. A mutation in CFTR causes a dysfunction of the salt and water balance. This causes dehydration of the secretions (thick mucous) and excessive loss of salt in sweat.

See more on med.stanford.edu

What Is A Carrier?

How Does CF occur?